Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/62013
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSzumowski, L.-
dc.contributor.authorSzufladowicz, E.-
dc.contributor.authorOrczkowski, M.-
dc.contributor.authorBodalski, R.-
dc.contributor.authorDerejko, P.-
dc.contributor.authorPrzybylski, A.-
dc.contributor.authorUrbanek, P.-
dc.contributor.authorKusmierczyk, M.-
dc.contributor.authorKozluk, E.-
dc.contributor.authorSacher, F.-
dc.contributor.authorSanders, P.-
dc.contributor.authorDangel, J.-
dc.contributor.authorHaissaguerre, M.-
dc.contributor.authorWalczak, F.-
dc.date.issued2010-
dc.identifier.citationJournal of Cardiovascular Electrophysiology, 2010; 21(8):877-882-
dc.identifier.issn1045-3873-
dc.identifier.issn1540-8167-
dc.identifier.urihttp://hdl.handle.net/2440/62013-
dc.description.abstract<h4>Aims</h4>The goal of this study was to describe mapping and ablation of severe arrhythmias during pregnancy, with minimum or no X-ray exposure. Treatment of tachyarrhythmia in pregnancy is a clinical problem. Pharmacotherapy entails a risk of adverse effects and is unsuccessful in some patients. Radiofrequency ablation has been performed rarely, because of fetal X-ray exposure and potential maternal and fetus complications. GROUP AND METHOD: Mapping and ablation was performed in 9 women (age 24-34 years) at 12-38th week of pregnancy. Three had permanent junctional reciprocating tachycardia, and 2 had incessant atrial tachycardia. Four of them had left ventricular ejection fraction < or =45%. One patient had atrioventricular nodal reciprocating tachycardia requiring cardioversion. Three patients had Wolff-Parkinson-White syndrome. Two of them had atrial fibrillation with ventricular rate 300 bpm and 1 had atrioventricular tachycardia 300 bpm. Fetal echocardiography was performed before and after the procedure.<h4>Results</h4>Three women had an electroanatomic map and ablation done without X-ray exposure. The mean fluoroscopy time in the whole group was 42 +/- 37 seconds. The mean procedure time was 56 +/- 18 minutes. After the procedure, all women and fetuses were in good condition. After a mean period of 43 +/- 23 months follow up (FU), all patients were free of arrhythmia without complications related to ablation either in the mothers or children.<h4>Conclusion</h4>Ablation can be performed safely with no or minimal radiation exposure during pregnancy. In the setting of malignant, drug-resistant arrhythmia, ablation may be considered a therapeutic option in selected cases.-
dc.description.statementofresponsibilityLukasz Szumowski, Ewa Szufladowicz, Michał Orczykowski, Robert Bodalski, Paweł Derejko, Andrzej Przybylski, Piotr Urbanek, Mariusz Ku´Smierczyk, Edward Ko´Zluk, Frederic Sacher, Prashanthan Sanders, Joanna Dangel, Michel Haissaguerre, and Franciszek Walczak-
dc.language.isoen-
dc.publisherFutura Publ Co-
dc.rights© 2010 Wiley Periodicals, Inc.-
dc.subjectablation-
dc.subjectatrioventricular (AV) node reentry-
dc.subjectfluoroscopy-
dc.subjectpregnancy-
dc.subjectsupraventricular tachycardia-
dc.subjectWolff-Parkinson-White syndrome-
dc.titleAblation of severe drug-resistant tachyarrhythmia during pregnancy-
dc.typeJournal article-
dc.identifier.doi10.1111/j.1540-8167.2010.01727.x-
pubs.publication-statusPublished-
dc.identifier.orcidSanders, P. [0000-0003-3803-8429]-
Appears in Collections:Aurora harvest 5
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.